Traumatic brain injury (TBI) is a significant health care issue that affects over ten million
people worldwide. Treatment options are limited with numerous failures resulting from single …

Finding new antidepressant agents is of high clinical priority given that many cases of major
depressive disorder (MDD) do not respond to conventional monoaminergic antidepressants …

The structure and functions of the central nervous system are influenced by environmental
stimuli, which also play an important role in brain diseases. Enriched environment (EE) …

Traumatic brain injuries (TBIs) affect more than 10 million patients annually worldwide,
causing long-term cognitive and psychosocial impairments. Frontal lobe TBIs commonly …

Approximately 10 million new cases of traumatic brain injury (TBI) are reported each year
worldwide with many of these injuries resulting in higher order cognitive impairments …

Cholinergic disruptions underlie attentional deficits following traumatic brain injury (TBI). Yet,
drugs specifically targeting acetylcholinesterase (AChE) inhibition have yielded mixed …

Gait disruptions following traumatic brain injury (TBI) are noted in the clinical population. To
date, thorough analysis of gait changes in animal models of TBI to allow for correlation of …

Alzheimer's disease (AD) is progressive neurodegeneration known as the most common
cause of dementia, and it is the sixth leading cause of death in older people. Given the …

Social behavior deficits are a common, debilitating consequence of traumatic brain injury
and stroke, particularly when sustained during childhood. Numerous factors influence the …

The administration of haloperidol (HAL) once-daily for 19 days after experimental traumatic
brain injury (TBI) impedes recovery and attenuates the efficacy of environmental enrichment …